Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 19, 2018New England Journal of MedicineOpen Access

Sorafenib for Advanced and Refractory Desmoid Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMrinal M. GounderMMMichelle R. MahoneyBTBrian A. Van Tine

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gounder et al. (2018) studied this question.

synapsesocial.com/papers/69dbc770387cf70698688b14https://doi.org/10.1056/nejmoa1805052
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patient Organizations and Research on Rare Diseases2011 · 45 citations
  2. 2Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials2017 · 133 citations
  3. 3An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)2017 · 421 citations